Why the study?
Does systematic screening for silent ischemia reduce the risk of cardiovascular events in asymptomatic high-risk patients with diabetes?
Does systematic screening for silent ischemia reduce the risk of cardiovascular events in asymptomatic high-risk patients with diabetes?
Systematic screening for silent ischemia in asymptomatic high-risk patients with diabetes does not reduce the risk of hard cardiovascular outcomes compared to usual care.
No takes yet. Share an insight, caveat, or question.
Does not support routine screening for silent ischemia in asymptomatic high-risk diabetes; confirms no cardiovascular benefit over usual care.
Lièvre et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: